Drug
Who makes iopamidol?
2 companies list iopamidol as a human prescription drug, including under the names ISOVUE 200, ISOVUE 250, ISOVUE 300, ISOVUE 370, ISOVUE-M. Forms: injection, solution. Routes: intrathecal, intravascular.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing iopamidol
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| BRACCO DIAGNOSTICS INCItaly | injection, solution | NDANDA018735, NDA020327 | 6 | 6 |
| Slate Run Pharmaceuticals, LLCUnited States | injection, solution | ANDAANDA215382, ANDA217134 | 6 | 1 |
Bulk ingredient listings
- BRACCO IMAGING SPA · 1 NDC
- DIVI'S LABORATORIES LIMITEDIndia · 1 NDC
- Zhejiang Starry Pharmaceutical Co., LtdChina · 1 NDC
Enquiry
Common questions
- Who makes iopamidol?
- 2 companies list iopamidol as a human prescription drug in the openFDA NDC Directory, led by BRACCO DIAGNOSTICS INC, Slate Run Pharmaceuticals, LLC. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic ISOVUE 200?
- 1 company lists iopamidol under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.
- Who supplies iopamidol active ingredient?
- 3 companies list iopamidol as a bulk ingredient, including BRACCO IMAGING SPA, DIVI'S LABORATORIES LIMITED, Zhejiang Starry Pharmaceutical Co., Ltd.